Back to results
US 2025/0137031 A1Published application
Assay device
OwnerJake HODGSON, Philip BAINESinventors
Life of this patent
Estimating the term…
Abstract
An assay device for use with samples of biological fluid, the assay device comprising: an N-acetyl-p-aminophenol (APAP) detection unit for detecting and/or measuring APAP in a biological fluid sample; and an alanine aminotransaminase 1 (ALT1) detection unit for detecting and/or measuring ALT1 in said biological fluid sample, wherein the APAP detection unit and the ALT1 detection unit act together as part of an assay process.
Claims20
An assay device for use with samples of biological fluid, the assay device comprising:
- an N-acetyl-p-aminophenol (APAP) detection unit for detecting and/or measuring APAP in a biological fluid sample;
- and
- an alanine aminotransaminase 1 (ALT1) detection unit for detecting and/or measuring ALT1 in said biological fluid sample, wherein the APAP detection unit and the ALT1 detection unit act together as part of an assay process.
A method of diagnosing an N-acetyl-p-aminophenol (APAP) overdose, the method comprising the steps of:
- introducing a biological fluid sample obtained from a patient into an assay device, wherein the assay device comprises an APAP detection unit and an alanine aminotransaminase 1 (ALT1) detection unit;
- detecting and/or measuring APAP in the biological fluid sample and detecting and/or measuring ALT1 in the biological fluid sample.
Dependencies are inferred from the claim text.